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Adipocyte differentiation is regulated by intracellular reactive oxygen species (ROS) genera-
tion and mitochondrial fission and fusion processes. However, the correlation between intra-
cellular ROS generation and mitochondrial remodeling during adipocyte differentiation is still
unknown. Here, we investigated the effect on adipocyte differentiation of 3T3-L1 cells of
intracellular ROS inhibition using N-acetyl cysteine (Nac) and Mito-TEMPO and of mito-
chondrial fission inhibition using Mdivi-1. Differentiated 3T3-L1 adipocytes displayed an
increase in mitochondrial fission, ROS generation, and the expression of adipogenic and
mitochondrial dynamics-related proteins. ROS scavenger (Nac or Mito-TEMPO) treatment
inhibited ROS production, lipid accumulation, the expression of adipogenic and mitochon-
drial dynamics-related proteins, and mitochondrial fission during adipogenesis of 3T3-L1
cells. On the other hand, treatment with the mitochondrial fission inhibitor Mdivi-1 inhibited
mitochondrial fission but did not inhibit ROS production, lipid accumulation, or the expres-
sion of adipogenic and mitochondrial dynamics-related proteins, with the exception of
phosphorylated Drp1 (Ser616), in differentiated 3T3-L1 adipocytes. The inhibition of mito-
chondrial fission did not affect adipocyte differentiation, while intracellular ROS production
decreased in parallel with inhibition of adipocyte differentiation. Therefore, our results indi-
cated that ROS are an essential regulator of adipocyte differentiation in 3T3-L1 cells.
Introduction
Obesity increases the number (hyperplasia) and size (hypertrophy) of adipocyte cells [1, 2]. It
can lead to many health problems, such as type 2 diabetes, insulin resistance, coronary heart
disease, and cancer [3]. Adipocytes are responsible for lipid uptake, synthesis, and storage in
the form of triglyceride (TG). Abnormal accumulation of stored TG in adipocytes causes
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obesity [4]. For this reason, many researchers have intensively studied the cellular and molecu-
lar mechanisms of adipocyte differentiation.
Adipogenesis is a cellular differentiation process by which preadipocytes become mature
adipocytes. Adipocyte differentiation is a complex developmental process accompanied by
coordinated changes in cell morphology, hormone sensitivity, and gene expression [5]. The
adipogenic hormone insulin triggers the induction of a series of transcription factors govern-
ing adipocyte differentiation [6, 7]. Insulin-mediated activation of protein kinase B (AKT) pro-
motes glucose uptake in adipocytes by leading vesicle of glucose transporter 4 (GLUT4) to
moving into the plasma membrane [8–10]. In addition, activation of AKT also enhances the
expression of peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer-
binding protein α (C/EBPα) by mediating insulin signals. PPARγ and C/EBPα are key adipo-
genic transcription factors that collaborate to elevate expression of adipocyte-specific genes,
such as GLUT4 and fatty acid-binding protein 4 (FABP4, also known as aP2) [11, 12]. Thus,
these genes are the key factors for regulating the adipocyte differentiation program.
Reactive oxygen species (ROS) have been introduced to be mainly produced by NADPH
oxidase 4 (Nox4) or mitochondrial enzymes after induction of adipocyte differentiation [12,
13]. Several researchers have considered that intracellular ROS are necessary for adipocyte
differentiation [13, 14]. Intracellular ROS generation through Nox4 occurs during the early
stages of insulin-mediated adipogenesis, which enhances insulin signaling transduction [15].
ROS generated at mitochondrial complex III are required to initiate adipocyte differentiation
through the induction of PPARγ transcriptional machinery [16]. In addition, ROS promote
adipocyte differentiation. Both ROS generation and adipocyte differentiation are lowered by
Nox4 knockdown and mitochondria specific antioxidants in mesenchymal stem cells [13, 17].
Adipogenesis is accelerated with increased expression of PPARγ in 3T3-L1 cells treated
with hydrogen peroxide [18]. Therefore, ROS are required for the process of adipocyte
differentiation.
Differentiation is a highly energy-demanding process [19]. Cellular bioenergetic function is
regulated by mitochondrial dynamics, a concept that encompasses the regulation of mitochon-
drial architecture mediated by movement, fusion, and fission. The fusion of mitochondrial
compartments allows the generation of interconnected mitochondria, whereas fission pro-
duces numerous mitochondrial fragments [20]. Mitochondrial fusion and fission processes
play an important role in energy metabolism, cell differentiation, and apoptotic cell death [21].
Interestingly, mitochondrial fusion and fission have a direct influence on TG accumulation in
the adipocyte. Differentiated 3T3-L1 adipocytes displayed fragmented and punctate mitochon-
dria surrounding lipid droplets, and an increase in the expression of the mitochondrial fission
protein dynamin-related protein 1 (Drp1) and the mitochondrial fusion protein mitofusion 2
(Mfn2) [22]. Meanwhile, the induction of mitochondrial fusion by silencing of Drp1 and fis-
sion 1 homolog protein (Fis1) causes a decrease in cellular TG content, while the induction of
mitochondrial fission by silencing of Mfn2 and optic atrophy-1 (OPA1) causes an increase in
cellular TG content in 3T3-L1 cells [23]. Taken together, these studies revealed that intracellu-
lar ROS generation, as well as mitochondrial dynamics regulation, contributes to the control
of adipocyte differentiation and lipid accumulation. However, the correlation between insulin-
induced ROS generation and mitochondrial remodeling during adipocyte differentiation is
not fully understood.
Here, we examined the effect of Mdivi-1, an inhibitor of the mitochondrial fission protein
Drp1, on insulin-induced lipid accumulation, adipogenic gene expression, and intracellular
ROS generation during differentiation of 3T3-L1 cells. In addition, we investigated the effect
of the broad ROS scavenger N-acetyl cysteine (Nac) and the mitochondria-targeted ROS
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scavenger Mito-TEMPO on mitochondrial morphology and the expression of mitochondrial
dynamics-related and adipogenic proteins.
Materials and methods
Cell culture, differentiation, and treatments
We purchased 3T3-L1 preadipocytes from the American Type Culture Collection (Manassas,
VA, USA). Cells were cultured at 37˚C/5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) containing 4500 mg/L glucose (Welgene, Korea), supplemented with 1% penicillin/
streptomycin (Welgene) and 10% bovine calf serum (Gibco, New Zealand). Cultures were
allowed to grow to confluency; after 48 h, cells were treated with a hormone mixture (MDI)
and 10% fetal bovine serum (FBS; Gibco) for 2 days. The MDI mixture was composed of 0.5
mM 3-isobutyl-1-methylxanthine, 1 μM dexamethasone, and 1 μg/mL insulin (Sigma-Aldrich,
MO, USA). Following the initiation of differentiation, the culture medium was replenished
every 2 days with DMEM (10% FBS) supplemented only with 1 μg/mL insulin for 6 days. We
used 3T3-L1 cells until they reached passage 10. All experiments were performed five times,
and each experiment was independently analyzed.
N-acetyl-L-cysteine (Nac; Sigma) or Mdivi-1 (Sigma) or Mito-TEMPO (Enzo Life Sciences,
NY, USA) treatments were initiated at 48 h after MDI treatment. 3T3-L1 cells were pretreated
with Nac, or Mdivi-1 or Mito-Tempo for 30 min and then treated with 1 μg/mL insulin.
Protein extraction and western blotting
Proteins were extracted from cells using PRO-PREP Protein Extraction Solution (iNtRON,
Korea). Cell extracts were separated by 12% SDS-PAGE and transferred onto nitrocellulose
membranes (Pall, FL, USA). Membranes were incubated with antibodies against PPARγ
(sc-271392, mouse monoclonal antibody, 1:1000, Santa Cruz, Dallas, TX, USA), C/EBPα
(sc-61, rabbit polyclonal antibody, 1:1000 Santa Cruz), Drp1 (sc-32898, rabbit polyclonal anti-
body, 1:2000 Santa Cruz), Mfn1 (sc-50330, rabbit polyclonal antibody, 1:2000 Santa Cruz),
Mfn2 (sc-50331, rabbit polyclonal antibody, 1:2000 Santa Cruz), β-actin (sc-47778, rabbit poly-
clonal antibody, 1:5000 Santa Cruz), AKT (#9272, rabbit polyclonal antiboy, 1:1000, Cell Sig-
naling, Danvers, MA, USA), phosphorylated (p)-AKT (Ser473) (#9271, rabbit polyclonal
antiboy, 1:1000, Cell Signaling), Glut4 (#2213, rabbit polyclonal antiboy, 1:1000, Cell Signal-
ing), FABP4 (aP2) (#2120, rabbit polyclonal antiboy, 1:1000, Cell Signaling), p-Drp1 (Ser616)
(#3455, rabbit polyclonal antiboy, 1:1000, Cell Signaling), p-Drp1 (Ser637) (#4867, rabbit poly-
clonal antiboy, 1:1000, Cell Signaling), Opa1 (612607, mouse monoclonal antibody, 1:5000,
BD Biosciences, Franklin Lakes, NJ, USA), superoxide dismutase (SOD)1 (LF-PA0013, rabbit
polyclonal antibody, 1:2000, AbFrontier, Seoul, Korea), SOD2 (LF-MA0030, mouse monoclo-
nal antibody, 1:2000, AbFrontier, Seoul, Korea), peroxiredoxin (Prx)1 (LF-PA0095, rabbit
polyclonal antibody, 1:2000, AbFrontier, Seoul, Korea), Prx2 (LF-MA0144, mouse monoclonal
antibody, 1:2000, AbFrontier, Seoul, Korea), Prx3 (LF-MA0044, mouse monoclonal antibody,
1:2000, AbFrontier, Seoul, Korea), Prx4 (LF-PA0009, rabbit polyclonal antibody, 1:2000,
AbFrontier, Seoul, Korea), Prx5 (LF-PA0210, rabbit polyclonal antibody, 1:2000, AbFrontier,
Seoul, Korea), and Prx6 (LF-PA0011, rabbit polyclonal antibody, 1:2000, AbFrontier, Seoul,
Korea). We used horseradish peroxidase-conjugated anti-mouse IgGs (31439, 1:5000, goat
polyclonal antibody, Thermo Fisher Scientific, Waltham, MA, USA), and horseradish peroxi-
dase-conjugated anti-rabbit IgGs (31460, 1:5000, goat polyclonal antibody, Thermo Fisher Sci-
entific) as secondary antibodies. Signals were visualized using Clarity Western ECL Substrate
(Bio-Rad, Hercules, CA, USA). Band intensities were analyzed using Multi Gauge version 3.0
(Fujifilm, Tokyo, Japan).
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Lentivirus generation and establishment of a stable cell line
The DsRed2-Mito gene was obtained from the pDsRed2-Mito vector (Clontech, CA, USA),
and the coding sequence was amplified by PCR with LA Taq polymerase (Takara, Shiga,
Japan). Amplified DsRed2-Mito was cloned into the entry pCR8/GW/TOPO vector (Invitro-
gen) to generate expression clones by performing LR recombination between the entry vector
and the destination vector, pLenti6.3/V5-DEST (Invitrogen). All three vectors, pLenti6.3-Ds-
Red2-Mito, psPAX2 packaging, and pMD.2G enveloping vectors, were transfected into
HEK293FT cells using Lipofectamine 2000 (Invitrogen). After 12 h of transfection, the
medium was exchanged for fresh medium. Then, 48 to 72 h after transfection, the lentivirus-
containing medium was harvested and purified with a 0.45-μm filter (Sartorius, Gottingen,
Germany).
pLenti6.3-DsRed2-Mito stable cell lines were generated by infecting 3T3-L1 cells with lenti-
viral vectors. During infection, polybrene (Sigma), which increases the transfection efficiency,
was added at 8 μg/mL, and the cells were cultured for 72 h. Single cells with high and stable
RFP expression were selected and cloned by sorting using a FACSAria II cell sorter. The sorter
was equipped with a laser turned to 488 nm. The RFP fluorescence from the cell was measured
and detected by PE (563~589 nm), and the collected data was quantified and analyzed using
FACSDiva version 6.1.3. The sorter then applied a charge to the droplet containing the cell to
sort into a collection tube.
Mitochondrial imaging
DsRed2-Mito-expressing 3T3-L1 cells were seeded on 0.1% poly-D-lysine-coated round cover-
slips. After MDI treatment, cells were treated with 1 μg/mL insulin for 6 days, with or without
Nac, or Mdivi-1, or Mito-Tempo. The cells were then washed twice with PBS and fixed with
4% paraformaldehyde in PBS for 3 h. Images were obtained using a LSM-710 confocal micro-
scope (Carl Zeiss, Germany) and processed using Zeiss LSM Image examiner, ZEN 2009 light
edition (Carl Zeiss,). Mitochondrial length was measured using ImageJ software (NIH, MD,
USA) and calculated using more than 50 mitochondria per cell from 20 cells. Mitochondria
were divided into different categories based on their length, i.e., less than 1, 1–3, and more
than 3 μm.
Detection of intracellular and mitochondrial ROS
Generation of intracellular and mitochondrial ROS was detected using 2,7-dichlorofluorescein
diacetate (CM-H2DCF-DA; Invitrogen, CA, USA) and MitoSOX (Invitrogen). At 8 days after
the initiation of differentiation, cells were treated with 1 μM CM-H2DCF-DA or 2 μM Mito-
SOX for 20 min at 37˚C. Cells were then washed with PBS and examined under a fluorescence
microscope (Leica Microsystems, Germany).
Oil Red O staining
Lipid accumulation was detected using Oil Red O (Sigma-Aldrich). At 8 days after the initia-
tion of differentiation, cells were fixed with 4% paraformaldehyde (Sigma-Aldrich) and then
stained with 0.35% Oil Red O solution for 3 h at 25˚C. Cells were washed three times using
double-distilled water. The red-stained lipid droplets were observed under a light microscope.
To quantify lipid accumulation, the Oil Red O was eluted by adding 100% isopropanol and
then absorbance was measured at 495 nm.
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Statistical analysis
Values are presented as the means ± SEM of five or more independent experiments. For group
comparisons, one-way analysis of variance followed by Dunnett’s multiple comparison tests
were performed with GraphPad Prism version 4.0 (GraphPad Software, CA, USA). A p value
less than 0.05 was considered statistically significant.
Results
Expression of adipogenic, mitochondrial dynamics, and antioxidant gene
proteins induced during adipocyte differentiation
Insulin treatment led 3T3-L1 to differentiation into mature adipocyte. We investigated the
altered expression of adipogenic, mitochondrial dynamics, and antioxidant genes during
adipocyte differentiation. First, we examined the expression of adipogenic genes at several
time points during adipocyte differentiation. Expression of the adipogenic markers PPARγ,
C/EBPα, aP2, and GLUT4 was significantly increased at day 8 compared to day 2, and phos-
phorylated AKT expression levels also gradually increased during adipocyte differentiation
(Fig 1A). Next, we investigated mitochondrial dynamics-related gene expression at several
time points during adipogenesis. Expression levels of mitochondrial fusion related proteins,
such as OPA1, Mfn1, and Mfn2, gradually increased, as did that of the mitochondrial fission
related protein, Drp1, and levels of phosphorylated serine 616 Drp1 also gradually increased
during adipocyte differentiation (Fig 1B). According to our previous study, insulin treatment
elevated expression of antioxidant enzymes in mature adipocytes [24]. We confirmed the
altered expression of antioxidant enzyme levels during adipocyte differentiation. Levels of the
antioxidant proteins Prx1, Prx2, Prx3, Prx5, and SOD2 gradually increased, and were espe-
cially high after 8 days (Fig 1C). Therefore, expression of adipogenic, mitochondrial dynamics,
and antioxidant gene proteins was increased during adipocyte differentiation.
Insulin-stimulated lipid accumulation is inhibited by antioxidants, but not
by the Drp1 inhibitor, Mdivi-1
Next, we investigated whether antioxidants or Mdivi-1 could reduce lipid accumulation in
mature adipocytes. We added insulin to 3T3-L1 cells pretreated with Nac, Mito-TEMPO, or
Mdivi-1 during adipocyte differentiation. As shown in our oil red o staining results, lipid was
significantly more accumulated in insulin-treated than in non-treated cells (Fig 2A and 2B).
Treatment with Nac or Mito-TEMPO and insulin resulted in a significant decrease in lipid
accumulation compared with insulin treatment alone (Fig 2A and 2B). However, insulin-
induced lipid accumulation was not reduced by Mdivi-1 (Fig 2A and 2B). Our results show
that antioxidant treatment results in inhibited insulin-stimulated lipid accumulation; however,
Mdivi-1 did not inhibit lipid accumulation.
Expression levels of insulin-induced adipogenic related genes are
inhibited by antioxidants, but not by the Drp1 inhibitor, Mdivi-1
After observing the above data, we investigated the changes in adipogenic gene expression.
Protein expression levels of the genes PPARγ, C/EBPα, and aP2 were significantly increased
following insulin treatment and dramatically decreased following treatment with Nac or Mito-
TEMPO. However, the expression of adipogenic genes was not decreased after Mdivi-1 treat-
ment (Fig 3A–3D). Levels of phosphorylated AKT and GLUT4, a downstream effector of
AKT, were significantly increased following treatment with insulin, and these decreased fol-
lowing treatment with Nac or Mito-TEMPO. However, the expression of phosphorylated Akt
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Fig 1. Changes in expression levels of adipogenic, antioxidant, and mitochondrial dynamics-related genes during adipogenesis of 3T3-L1
cells. 3T3-L1 cells were harvested daily for 8 days during differentiation of pre-adipocytes into adipocytes following MDI treatment. Cells were lysed, and
protein extracts were subjected to western blot analysis with the indicated antibodies: adipogenic genes (PPARγ, C/EBPα, p-AKT, AKT, GLUT4, and
aP2), mitochondrial dynamics-related genes (OPA1, Mfn1, Mfn2, p-Drp1 (Ser616), and Drp1), and antioxidant genes (Prx1, Prx2, Prx3, Prx5, and SOD2).
Data in the bar graphs represent the means ± SEM of three independent experiments. *p<0.05, **p < 0.01, ***p < 0.001, compared with early
differentiated adipocytes (day 1).
https://doi.org/10.1371/journal.pone.0185764.g001
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and GLUT4 was not decreased following treatment with Mdivi-1 (Fig 3A, 3E and 3F). These
results indicate that antioxidants such as Nac or Mito-TEMPO inhibit lipid accumulation in
state of adipocyte differentiation through alleviating the expression levels of adipogenic pro-
teins. However, Mdivi-1 does not inhibit the expression levels of adipogenic proteins.
Insulin treatment during adipocyte differentiation results in increased
mitochondrial fission that is attenuated by Nac, Mito-TEMPO, and Mdivi-1
We investigate whether Nac, Mito-TEMPO, and Mdivi-1 treatment affects mitochondrial mor-
phology. To investigate mitochondrial morphology, we stably expressed a mitochondria-target-
ing DsRed2 (DsRed2-Mito) plasmid in 3T3-L1 cells and observed the morphological changes
in mitochondria of mature adipocytes by confocal microscopy. Insulin-induced mature adipo-
cytes showed increased formation of punctate mitochondria and mitochondrial fragmentation
(Fig 4A). The average length of mitochondria significantly decreased in insulin-induced mature
adipocytes (Fig 4B). The number of fragmented mitochondria significantly increased, and the
number of tubular mitochondria considerably decreased compared to the untreated 3T3-L1
cells, although numbers of elongated mitochondria were unchanged (Fig 4C). However, treat-
ment with Nac, Mito-TEMPO, and Mdivi-1 resulted in a significant decrease in fragmented
mitochondria (Fig 4A). The average length of mitochondria significantly increased following
Fig 2. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 on lipid accumulation in 3T3-L1 cells
during adipogenesis. 3T3-L1 adipocytes were pretreated with 10 mM Nac, 200 μM Mito-TEMPO, or 50 μM
Mdivi-1 for 30 min and then with insulin during adipogenesis. (A) Accumulated lipid was stained with Oil Red O
reagent and quantified by absorbance at 490 nm (B). Data in the bar graph represent the means ± SEM of
three independent experiments. *p < 0.05, ***p < 0.001, compared with untreated or insulin-treated cells.
###p<0.001, compared with insulin-treated cells.
https://doi.org/10.1371/journal.pone.0185764.g002
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treatment with Nac, Mito-TEMPO, and Mdivi-1, and the number of fragmented and tubular
mitochondria clearly reversed compared with the insulin-treated mature adipocytes, although
treatment with Mdivi-1 caused a slight change (Fig 4B and 4C). Accordingly, we investigated
the protein expression of mitochondrial dynamics genes in 3T3-L1 cells after adipocyte
differentiation. The results showed that levels of OPA-1, Mfn1, and Mfn2, associated with
mitochondrial fusion, were increased in mature adipocytes after insulin treatment (Fig 5A–
5D). Furthermore, levels of Drp1 phosphorylated at serine 616 increased in mature adipocytes,
indicating mitochondrial fission (Fig 5A and 5E). Interestingly, protein expression of these
genes was significantly decreased by Nac and mito-TEMPO, and phosphorylated Drp1 was
slightly decreased compared with insulin-only treatment (Fig 5). Thus, our results clearly show
that antioxidants and a Drp-1 inhibitor prevent mitochondrial fission and increase mitochon-
drial dynamics during insulin-induced adipocyte differentiation.
Insulin-stimulated ROS production is inhibited by Nac and Mito-TEMPO,
but not by Mdivi-1
To investigate levels of ROS production, we cultured 3T3-L1 cells with Nac, Mito-TEMPO, or
Mdivi-1 during adipocyte differentiation. As shown in our ROS staining results, cytosolic ROS
Fig 3. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 on the expression of adipogenic
related genes in 3T3-L1 cells after differentiation. 3T3-L1 adipocytes were pretreated with 10 mM Nac,
200 μM Mito-TEMPO, or 50 μM Mdivi-1 for 30 min and then with insulin during adipogenesis. Cells were lysed
and proteins were subjected to western blot analysis with the indicated antibodies: adipogenic genes (PPARγ,
C/EBPα, p-AKT, AKT, GLUT4, and aP2). Data in the bar graphs represent the means ± SEM of three
independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, compared with untreated cells. #p < 0.05,
##p < 0.01, ###p < 0.001 compared with insulin-treated cells.
https://doi.org/10.1371/journal.pone.0185764.g003
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levels were increased following insulin treatment using CM-H2DCF-DA, and treatments with
Nac or Mito-TEMPO resulted in a significant decrease in cytosolic ROS production. With
Mito-SOX staining, mitochondrial ROS levels were also increased following insulin treatment,
and treatment with Nac or Mito-TEMPO resulted in a significant decrease in mitochondrial
ROS production. However, treatment with Mdivi-1 resulted in no decrease of either cytosolic
or mitochondrial ROS (Fig 6A–6C). Our results show that Nac and Mito-TEMPO treatment
results in decreased insulin-induced ROS production; however, Mdivi-1 treatment does not
inhibit ROS production.
Fig 4. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 treatment on mitochondrial morphology in 3T3-L1 cells after differentiation.
(A) DsRed2-Mito-expressing 3T3-L1 cells treated with 1 μg/mL insulin for 6 days with or without 10 mM Nac, 200 μM Mito-TEMPO, or 50 μM Mdivi-1 after
MDI treatment for 48 h. Mitochondrial morphology was determined by confocal microscopy. (B) Graph showing average mitochondrial length. (C) Graph
indicating mitochondrial morphology. Data in the bar graphs represent the means ± SEM of three independent experiments. *p < 0.05, **p < 0.01,
***p < 0.001 compared with untreated or insulin-treated cells. ##p < 0.01, ###p < 0.001 compared with untreated cells.
https://doi.org/10.1371/journal.pone.0185764.g004
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Expression of insulin-induced antioxidant gene proteins is inhibited by
Nac and Mito-TEMPO, but not by Mdivi-1 treatment
After observing the above data, we also investigated the altered expression of antioxidant
genes. Protein expression levels of Prx1, Prx2, Prx3, Prx5, SOD1, and SOD2 were significantly
increased following insulin treatment, and highly decreased following treatment with Nac or
Mito-TEMPO. However, the expression of these antioxidant genes was not decreased after
Mdivi-1 treatment (Fig 7A–7G). These results indicate that ROS scavenger chemicals inhibit
antioxidant gene expression during adipocyte differentiation by decreasing levels of ROS pro-
duction. However, Mdivi-1 does not inhibit the expression levels of antioxidant proteins.
Discussion
Adipogenesis is a differentiation process in which preadipocytes become mature adipocyte
cells; it is a complex and programmed process involving coordinated changes in morphology,
hormone sensitivity, and gene expression [5]. In state of adipocyte differentiation, the cells
require high level of energy, which elevates mitochondrial metabolism. This result shows that
elevated ROS generation is essential for both the expression of key adipogenesis-related genes
and transition from preadipocyte to mature adipocyte [13, 15, 19, 25]. Mitochondria are highly
dynamic organelles and undergo continuous fission and fusion events in physiological situa-
tions [16, 26]. A previous study revealed that mitochondrial biogenesis and remodeling are
essential for adipose differentiation and are influenced by insulin [27]. In preadipocytes, mito-
chondria are elongated and well organized. In contrast, in mature adipocytes, they are frag-
mented, punctate, and redistributed around lipid droplets [28]. Mitochondrial fission and
fusion have an influence on lipid accumulation in adipocytes [29]. The fragmentation of mito-
chondrial tubules is associated with enhanced production of ROS [30]. However, the correla-
tion between insulin-induced ROS production and mitochondrial remodeling networks on
lipid accumulation during adipocyte differentiation remains unclear.
Fig 5. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 on mitochondrial dynamics-related
genes in 3T3-L1 cells after differentiation. 3T3-L1 adipocytes were pretreated with 10 mM Nac, 200 μM
Mito-TEMPO, or 50 μM Mdivi-1 for 30 min and then with insulin during adipogenesis. Cells were lysed and
proteins were subjected to western blot analysis with the indicated antibodies: mitochondrial dynamics-related
genes (OPA1, Mfn1, Mfn2, p-Drp1 (Ser616), and Drp1). Data in the bar graphs represent the means ± SEM of
three independent experiments. **p < 0.01, ***p < 0.001, compared with untreated cells. #p < 0.05,
##p < 0.01, ###p < 0.001 compared with insulin-treated cells.
https://doi.org/10.1371/journal.pone.0185764.g005
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Several studies involving adipocytes have shown that insulin is a potent adipogenic hor-
mone that induces a series of transcription factors during differentiation of pre-adipocytes
into mature adipocytes [18, 31]. Insulin also stimulates ROS generation through mitochondrial
metabolism and Nox4 activation, resulting in promotion of adipocyte differentiation [15, 25].
This Nox4-induced ROS generation is concerned with both enhanced insulin receptor autop-
hosphorylation and the inhibition of cellular protein tyrosine phosphatase (PTP) activity by
oxidation, resulting in elevation of the insulin signaling pathway [32]. ROS generation by
Nox4 mediates the insulin signaling cascade in adipocytes. Treatment of H2O2 in 3T3-L1 cells
induced the activation of the PI3K/AKT signaling cascade, increased basal GLUT4 vesicle
translocation into plasma membrane, and ultimately increased cellular glucose uptake [33].
Among adipogenesis-related transcription factors, C/EBPα and PPARγ are key factors of
white adipocyte differentiation [7, 34]. C/EBP β is induced by increased production of ROS in
early-stage adipocyte differentiation, and then increased expression of PPARγ and aP2 acceler-
ates mature adipocyte differentiation [35–37]. In the current study, we investigated whether
the expression of adipogenic genes, antioxidant enzymes, and ROS generation increased after
insulin treatment. As expected, we found that levels of adipogenic protein expression gradually
Fig 6. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 treatment on intracellular and mitochondrial ROS production in 3T3-L1 cells
after differentiation. (A) 3T3-L1 adipocytes were pretreated with 10 mM Nac, 200 μM Mito-TEMPO, or 50 μM Mdivi-1 for 30 min and then with insulin
during adipogenesis. After 8 days of the initiation of differentiation, cells were used in CM-H2DCF-DA (A, B) and Mito-SOX (A, C) stained assays. Data in
the bar graphs represent the means ± SEM of three independent experiments. ***p < 0.001 compared with untreated or insulin-treated cells.
https://doi.org/10.1371/journal.pone.0185764.g006
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increased during insulin-induced adipocyte differentiation (Fig 1A). Furthermore, the adipo-
genic gene levels were significantly reduced by the antioxidant Nac (Fig 3). These results cor-
roborated those of our previous study [24]. Therefore, insulin-induced adipogenic-related
genes mediate ROS levels in differentiated 3T3-L1 cells.
During adipogenesis, mitochondria adapt to the increased numbers of lipid droplets by
fragmentation, network redistribution, and uncoupling of respiration [22]. Mitochondrial
fragmentation is regulated by Drp1, and fusion is controlled by Mfn1, Mfn1, and Opa1 [38].
Furthermore, Drp1 activity is regulated by phosphorylation. Therefore, under conditions such
as oxidative stress and high glucose stimulation, phosphorylation of Drp1 (at Ser616) increases
[39, 40]. In this study, our data show that the protein expression of Drp1, Mfn1, Mfn2, and
Opa1 increased during 3T3-L1 adipocyte differentiation (Fig 1B); these results agree with
Fig 7. Effect of N-acetyl cysteine (Nac), Mito-TEMPO, and Mdivi-1 treatment on antioxidant related genes in 3T3-L1 cells after differentiation.
(A) 3T3-L1 adipocytes were pretreated with 10 mM Nac, 200 μM Mito-TEMPO, or 50 μM Mdivi-1 for 30 min and then with insulin during adipogenesis.
Cells were lysed and proteins were subjected to Western blot analysis analysis with the indicated antibodies; antioxidant genes (Prx1, Prx2, Prx3, Prx5,
SOD1, and SOD2). Data in the bar graph represent the means ± SEM of three independent experiments. * p< 0.05, ** p< 0.01, *** p< 0.001, compared
with not treated cell. # p< 0.05, ## p< 0.01, ### p< 0.001, compared with insulin-treated cell.
https://doi.org/10.1371/journal.pone.0185764.g007
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those of a previous study [22]. Accordingly, mitochondrial dynamics is required for the accu-
mulation of lipid droplets.
The correlation between oxidative stress and mitochondrial fission has emerged in numer-
ous studies. Oxidative stress is thought to be a regulator of mitochondrial fragmentation, and
inhibition of ROS effectively represses mitochondrial fragmentation [23, 41–44]. In addition,
differentiation is a highly energy-demanding status, and mitochondrial ROS are required to
initiate adipocyte differentiation [19, 25]. In this study, we investigated mitochondrial mor-
phological changes after insulin-induced ROS generation in mature adipocytes. First, we chose
to investigate lipid accumulation and the effect of Mito-TEMPO on mitochondrial ROS pro-
duction in insulin-induced mature adipocytes. Our results show that Mito-TEMPO not only
reduces mitochondrial ROS, but also represses lipid accumulation (Figs 2 and 6). Furthermore,
increased mitochondrial length and numbers of tubular mitochondria, as well as reduced
numbers of fragmented mitochondria, resulted from treatment with Mito-TEMPO (Fig 4).
Next, a chemical inhibitor of Drp1 have identified Dynasore and Mdivi-1 through previous
study. Dynasore inhibits GTPase activity by binding of Dynamin GTPase domain, which is
included on both Dynamins and Drp1, while Mdivi-1 only inhibits Drp1 assembly on outer
membrane of mitochondria [45, 46]. Thus, we chose Mdivi-1 to confirm the correlation
between Drp1-mediated mitochondrial fission and adipocyte differentiation. We investigated
whether Mdivi-1, a specific Drp1 inhibitor, could prevent lipid accumulation in insulin-
induced mature adipocytes. A previous study showed that inhibition of Drp1 or overexpres-
sion of Mfn2, a mitochondrial fusion marker, resulted in decreased TG accumulation in
3T3-L1 adipocytes [29]. Unexpectedly, our data showed that Mdivi-1 did not inhibit adipo-
genic gene expression and lipid accumulation in mature adipocytes (Figs 2 and 3), and mito-
chondrial ROS was also not inhibited by Mdivi-1 (Fig 6). However, although the protein
expression of Drp1 (Ser616) decreased only slightly, treatment with Mdivi-1 resulted in signifi-
cantly increased mitochondrial length and numbers of tubular mitochondria, and reduced
numbers of fragmented mitochondria than insulin-only treated mature adipocytes (Figs 4 and
5). According to previous studies, mitochondrial ROS regulates C/EBPα and PPARγ, which
can lead to adipocyte differentiation [47–49]. In the current study, our results indicate that
mitochondrial ROS levels are not reduced by Mdivi-1, and it does not inhibit lipid accumula-
tion. Therefore, although emerging data suggest that mitochondrial fission is inhibited by
Mdivi-1, lipid accumulation is more influenced by ROS generation.
Studies in humans have revealed that adipose tissue from obese patients is associated with
increased systemic oxidative stress, which might indicate a target for new therapies for obe-
sity-related metabolic syndrome [50]. Our previous study also suggests that antioxidant mate-
rials could potentially be used to prevent obesity [24]. Accordingly, we investigated the levels
of antioxidants such as Prxs and SOD. The results showed that these levels gradually increased
during the transition from pre-adipocyte to mature adipocyte, which corresponded with
increased ROS generation (Fig 1), and these increases were reversed by antioxidant treatment
with Nac and Mito-TEMPO (Fig 7). However, levels of Prxs and SOD were not decreased by
Mdivi-1 due to the lack of inhibition of ROS generation (Fig 7). We thought that maybe ROS
are an upstream regulator of mitochondrial fragmentation. Meanwhile, Prx1, Prx3, and Prx5
play important roles in maintaining normal adipocyte characteristics. Furthermore, it have
been reported that SOD expression as well as activity rose during adipocyte differentiation in
3T3-L1 [13, 51]; therefore, redox regulation by antioxidants is required for adipocyte differen-
tiation. However, the precise role of antioxidants in the regulation of mitochondrial dynamics
during adipocyte differentiation remains unclear. Furthermore, there are still necessary to
study about the effect of C/EBP β gene expression and mitochondria fission with or without
antioxidant enzyme on early stage adipocyte differentiation. Thus, we will be investigate the
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effect of C/EBP β gene expression and mitochondria fission when it ectopic overexpression of
the antioxidant gene such as peroxiredoxin 2 or 5 during induction or early stage of differenti-
ation in 3T3L1 and Primary pre-adipocyte from mice white adipose tissue.
In conclusion, our results demonstrate that the regulation of adipogenic genes and altered
mature adipocytes are influenced by ROS generation, and merely suppressing mitochondrial
fragmentation does not inhibit lipid accumulation during adipocyte differentiation. These
findings provide a fundamental basis for understanding the correlation between ROS and
mitochondrial dynamics in adipocyte differentiation, which may lead to the development of
ROS-based therapeutic strategies for the suppression of obesity.
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